文章摘要
邹勇波 李玲 甘华葵 戴红梅 刘斌 刘永华.持续皮下胰岛素注射对 2 型糖尿病合并肺部感染患者的疗效分析[J].,2015,15(2):284-286
持续皮下胰岛素注射对 2 型糖尿病合并肺部感染患者的疗效分析
The Curative Effect Analysis of Continuous Subcutaneous Insulin Infusion inType 2 Diabetes Patients Accompanied with Pulmonary Infection
  
DOI:
中文关键词: 2 型糖尿病  肺部感染  胰岛素
英文关键词: Type 2 diabetes  Pulmonary infection  Insulin
基金项目:
作者单位
邹勇波 李玲 甘华葵 戴红梅 刘斌 刘永华 重庆医科大学内江附属医院 / 内江市第一人民医院内分泌科 川北医学院附属医院内分泌科 
摘要点击次数: 906
全文下载次数: 977
中文摘要:
      目的: 分析持续皮下注射胰岛素对 2 型糖尿病( T2DM)合并肺部感染患者的临床疗效。 方法: 将我院 2010 年 6 月至 2013 年 6 月 收治的 86 例 2 型糖尿病合并肺部感染患者随机分为 2 组,分别采用 胰岛素泵持续皮下注射(治疗 组)和多 次皮下注射胰岛素 (对照组), 观察患者血糖指标、血糖达标时间、低血糖发生率及肺部感染治愈率情况。 结果: 治疗 后,两组患者的血糖均得到控制, 治疗组的血糖指标变化、血糖达标时间及住院时间均优于对照组,差异均有统计学意义(均 P<0.05)。 治疗组的低血糖发生率明显 低于对照组, 而肺部感染治愈率显著高于对照组,差异均有统计学意义(均 P<0.05)。 结论: 胰岛素泵持续皮下胰岛素注射在治疗 2 型糖尿病合并肺部感染患者中使用, 血糖达标迅速,降低低血糖发生率, 缩短住院时间,提高感染治愈率, 临床效果好。
英文摘要:
      Objective:To analyze the clinical effect of continuous subcutaneous insulin infusion treatment of type 2 diabetes with pulmonary infection.Methods:86 cases of type 2 diabetes complicated with pulmonary infection from June 201 0 to June 201 3 in our hospital were randomly divided into two groups, namely treatment group and control group. The treatment group were treated by continuous subcutaneous insulin infusion, and the control group were given hypodermic injection repeatedly. The patients' blood glucose index , time to reach normal level of blood glucose, the incidence of hypoglycemia and the clinical effect were analyzed.Results:Both of the two groups reached the target level of blood glucose after treatment, but the mean time of blood sugar controlling and the duration of hospital stays was shorter in the treatment group than in the control group, the difference was statistically significant (all P<0.05). The incidence of hypoglycemia and the curative ratio of pulmonary infection in the treatment group was significantly lower than in the control group, and the difference was statistically significant (all P<0.05)Conclusion:Continuous subcutaneous insulin infusion treatment is effective in patients of type 2 diabetes with pulmonary infection, it can effectively reduce the incidence of hypoglycemia, shorten the hospital stays and increase the curative ratio of pulmonary infection, thus is worth clinical promotion.
查看全文   查看/发表评论  下载PDF阅读器
关闭